[
  {
    "ts": null,
    "headline": "Vertex Pharma CEO Buys the Stock Dip",
    "summary": "Biotech Vertex Pharmaceuticals stock tumbled on news of disappointing drug data. CEO Reshma Kewalramani paid nearly $4 million to buy shares.",
    "url": "https://finnhub.io/api/news?id=5b854ab3bd6c8b42493b6412df718e1092661218c0ff586327f286042618b3dd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755294720,
      "headline": "Vertex Pharma CEO Buys the Stock Dip",
      "id": 136376535,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Biotech Vertex Pharmaceuticals stock tumbled on news of disappointing drug data. CEO Reshma Kewalramani paid nearly $4 million to buy shares.",
      "url": "https://finnhub.io/api/news?id=5b854ab3bd6c8b42493b6412df718e1092661218c0ff586327f286042618b3dd"
    }
  },
  {
    "ts": null,
    "headline": "Is This Beaten-Down Stock a Buy on the Dip?",
    "summary": "It's the second time this year the stock has slumped significantly in one day, and it might represent another attractive entry point.",
    "url": "https://finnhub.io/api/news?id=f37e49a6e7be3b3b55bbfc2b04fd98475a67d222d0835299f8f32de5bbff0cdd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755264600,
      "headline": "Is This Beaten-Down Stock a Buy on the Dip?",
      "id": 136376536,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "It's the second time this year the stock has slumped significantly in one day, and it might represent another attractive entry point.",
      "url": "https://finnhub.io/api/news?id=f37e49a6e7be3b3b55bbfc2b04fd98475a67d222d0835299f8f32de5bbff0cdd"
    }
  },
  {
    "ts": null,
    "headline": "2 Growth Stocks That Are No-Brainer Buys Right Now",
    "summary": "These stocks have outperformed broader equities over the past decade and still have room to run.",
    "url": "https://finnhub.io/api/news?id=3034f138ccf8afe17a19a10851592b1790275ae5b18191db0dce953dea32d5bf",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755261000,
      "headline": "2 Growth Stocks That Are No-Brainer Buys Right Now",
      "id": 136367931,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "These stocks have outperformed broader equities over the past decade and still have room to run.",
      "url": "https://finnhub.io/api/news?id=3034f138ccf8afe17a19a10851592b1790275ae5b18191db0dce953dea32d5bf"
    }
  }
]